Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
200
Trial Sponsor
Clinical Trial Start Date
2008
0Primary Completion Date
2009
0Study Completion Date
2009
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 10
Official Name
A Phase I Study of Oral Palifosfamide Tris in Advanced, Refractory, Solid Tumors0
Last Updated
May 5, 2008
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
oral palifosfamide tris0
Study summary
The study of maximum tolerated dose and safety of oral palifosfamide tris capsules in advanced, refractory, solid tumors
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
